Genome-wide association studies (GWAS) have associated NAFLD with single nucleotide polymorphisms (SNPs), mainly in the PNPLA3 (patatin-like phospholipase domain containing 3), the TM6SF2 (transmembrane 6 superfamily member 2), the MBOAT7 (membrane bound O acyltransferase 7), and the GCKR (glucokinase regulator) [17]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.